Today, the Cystic Fibrosis Foundation announced that it has awarded up to $2.17 million to Beyond Air® to support the development of a portable inhaled nitric oxide treatment for nontuberculous mycobacteria, difficult-to-treat bacteria that infect the lungs of people with cystic fibrosis.
Site Search
Dr. Steven Rowe will support mission to cure cystic fibrosis by leading the Foundation’s research strategy, focusing on genetic therapies
The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. Join the team that’s adding tomorrows.
Learn more about our Board and Officer Conflict of Interest Policy.
Learn more about the Cystic Fibrosis Foundation’s Code of Ethics.
Breadth of expertise in business, philanthropy, community engagement, and venture capital to help advance Foundation’s mission
Groups urging need for revitalizing antimicrobial development call for passage of the bill this year
As a highly committed National Corporate Champion — Daugherty employees have been involved for nearly 15 years and have raised more than $275,000 to help advance the Foundation’s mission. Their steadfast support continues to fuel some of the most innovative CF research in the world.
Brown to join Foundation in April 2023, bringing more than 20 years of experience in nonprofit communications and journalism, with a focus on health and science